The expected decline, compensatory drop, in the age group 60–64 years was marginally non-significant for any breast carcinoma and invasive breast carcinoma.
← all excerpts
Overdiagnosis due to breast cancer screening: updated estimates of the Helsinki service study in Finland.
1
—
—